IL33 and gastric cancer: High serum IL-33 concentration is reported to be associated with a poor prognosis in gastric cancer patients [107], and in vitro experiments suggest that IL-33 confers chemo-resistance [108] and increases invasiveness [109] to gastric cancer cells.